Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 94
(PREVENTING) THE COMING EPIDEMIC: HIV IN YOUTH
Shannon L Hader
US Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 8:30 AM-9:30 AM
ANTIVIRAL VACCINE DEVELOPMENT FROM A (AIDS) TO Z (ZIKA)
Barney S. Graham
NIAID, National Institutes of Health, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 8:30 AM-9:30 AM
INTENSITY OF SUPPRESSION LINKED WITH SHIFTING COMPARTMENTALIZATION OF CNS HIV DNA
Benjamin B Gelman
University of Texas Medical Branch , Galveston, TX, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
CNS PARENCHYMA AND CHOROID PLEXUS, NOT CSF, ARE VIRAL RESERVOIRS IN MONKEYS WITH AIDS
Jaclyn Mallard
Boston College, Chestnut Hill, MA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
EARLY MACROPHAGE-INDEPENDENT INFLAMMATION AND SHIV-RNA IN CNS IN A RHESUS SHIV MODEL
Sandhya Vasan
Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
DEEP SEQUENCING REVEALS RARE CNS COMPARTMENTALIZATION IN ACUTE HIV-1 INFECTION
Rujipas Sirijatuphat
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
CD4/CD8 RATIO ASSOCIATES WITH NEUROPSYCHOLOGIC PERFORMANCE DURING EARLY HIV INFECTION
Leah T Le
Yale University, New Haven, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ASYMPTOMATIC HIV-1 CSF ESCAPE IS UNCOMMON AND IS NOT ASSOCIATED WITH NEURONAL DAMAGE
Sarah Beth Joseph
University of North Carolina, Chapel Hill, NC, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
GENETIC VARIATION IN EIF2AK3 IS ASSOCIATED WITH NEUROCOGNITIVE IMPAIRMENT IN HIV
Scott Letendre
University of California, San Diego, San Diego, CA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
CEREBRAL SMALL-VESSEL DISEASE IN HIV-INFECTED PATIENTS WELL CONTROLLED ON CART
Dominique Costagliola
Sorbonne Universités, INSERM, UPMC Univ Paris 06, PARIS cedex 13, France
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
RESISTANCE EMERGENCE IN MACAQUES ADMINISTERED CABOTEGRAVIR LA DURING ACUTE INFECTION
Gerardo Garcia-Lerma
CDC, Atlanta , GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA
Renee Heffron
University of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF TENOFOVIR
Sharon L Hillier
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ABUNDANCE OF PENILE ANAEROBES, IL-8, AND THE RISK OF HIV ACQUISITION, RAKAI, UGANDA
Lance Price
George Washington University, Washington, DC, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
DAPIVIRINE RING USE DOES NOT DIMINISH THE EFFECTIVENESS OF HORMONAL CONTRACEPTION
Jennifer Balkus
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
STD PARTNER SERVICES TO MONITOR AND PROMOTE PREP USE AMONG MEN WHO HAVE SEX WITH MEN
David A Katz
University of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
CHALLENGES OF TRANSLATING PREP INTEREST INTO UPTAKE AMONG YOUNG BLACK MSM IN ATLANTA
Charlotte-Paige Melanie Rolle
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ON DEMAND POST EXPOSURE PROPHYLAXIS WITH DOXYCYCLINE FOR MSM ENROLLED IN A PREP TRIAL
Jean-Michel Molina
Hôpital St Louis, Paris, France
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
IMMUNE CORRELATES OF HIV ACQUISITION
Krystelle Nganou Makamdop
NIH, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
MARKED CHANGES IN CELLULAR BUT NOT VIRUS TRANSCRIPTOME IN CD4-LOW HIV-INFECTED CELLS
Joseph P Casazza
National Institutes of Health, USA, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
SINGLE CELL TRANSCRIPTIONAL PROFILING REVEALS A NOVEL POPULATION OF MUCOSAL TFH CELLS
Andrew R Rahmberg
Emory University, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
HIGH HIV PERMISSIVITY OF T FOLLICULAR REGULATORY CELLS IS RELATED TO KI67 EXPRESSION
Elizabeth Connick
University of Arizona, Tucson, AZ, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
VIRION INCORPORATION OF INTEGRIN α4β7: IMPLICATIONS FOR HIV-1 PATHOGENESIS
Christina Guzzo
NIH, Bethesda, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
DEFINING THE NATURE OF CD8+ T-CELL RESPONSES IN LYMPH NODES OF HIV ELITE CONTROLLER
Son Nguyen
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
HIV-SPECIFIC BINDING ANTIBODY PROFILES ASSOCIATED WITH BROADLY NEUTRALIZING ACTIVITY
Claus Kadelka
University of Zurich, Zurich, Switzerland
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
THE IMPACT OF HIV-GENETICS ON IMPRINTING ANTIBODY RESPONSES: THE SWISS 4.5K SCREEN
Roger Kouyos
University of Zurich, Zurich, Switzerland
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
A MULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS
Timothy Rodwell
FIND, Geneva, Switzerland
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
WHOLE-GENOME SEQUENCING AND SPATIAL ANALYSIS OF XDR TB TRANSMISSION IN SOUTH AFRICA
Kristin Nicole Nelson
Emory University, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
SIX-MONTH IPT REDUCES MORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTS WITH HIGH CD4
Anani D Badje
Inserm U1219, BORDEAUX, France
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
THE ESSENTIALITY OF INH DURING THE FIRST 14 DAYS OF TB THERAPY: THE A5307 EBA TRIAL
Florian von Groote-Bidlingmaier
TASK Applied Science, Cape Town, South Africa
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
THE NIX-TB TRIAL OF PRETOMANID, BEDAQUILINE AND LINEZOLID TO TREAT XDR-TB
Francesca Conradie
University of the WItswatersrand, Johannesburg, South Africa
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS
Graeme Meintjes
University of Cape Town, South Africa, South Africa
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
AMBITION-CM: HIGH-DOSE LIPOSOMAL AMPHOTERICIN FOR HIV-RELATED CRYPTOCOCCAL MENINGITIS
Joseph N Jarvis
Center for Disease Control and Prevention, Gaborone, Botswana
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
A RANDOMISED CONTROLLED TRIAL OF INDUCTION THERAPY OF TALAROMYCES MARNEFFEI INFECTION
Thuy Le
Oxford University Clinical Research Unit, Vietnam, Ho Chi Minh, Viet Nam
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
DISCUSSION OF ORAL ABSTRACT SESSION 7 – TB AND OTHER OPPORTUNISTIC INFECTIONS
CHAIR
Constance A Benson
University of California at San Diego, San Diego, CA, USA
OA7: A MULTICENTER DIAGNOSTIC ACCURACY STUDY OF THE XPERT ULTRA FOR TUBERCULOSIS DIAGNOSIS
Timothy Rodwell
FIND, Geneva, Switzerland
OA7: SIX-MONTH IPT REDUCES MORTALITY INDEPENDENTLY OF ART IN AFRICAN ADULTS WITH HIGH CD4
Anani Badje
INSERM, Bordeaux, France
OA7: RANDOMIZED CONTROLLED TRIAL OF PREDNISONE FOR PREVENTION OF PARADOXICAL TB-IRIS
Graeme Meintjes
Univ of Cape Town, Cape Town, South Africa
from CROI 2017 on February 15, 2017 12:15 PM-1:15 PM
DISCUSSION OF ORAL ABSTRACT SESSION 8 – COMMON BEDFELLOWS: PREP, STIS, AND THE MICROBIOME
CHAIR
Wafaa El-Sadr
ICAP at Columbia University, New York, NY, USA
OA8: RESISTANCE EMERGENCE IN MACAQUES ADMINISTERED CABOTEGRAVIR LA DURING ACUTE INFECTION
Gerardo Garcia-Lerma
CDC, Atlanta, GA, USA
OA8: DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA
Renee Heffron
Univ of Washington, Seattle, WA, USA
OA8: IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF TENOFOVIR
Sharon Hillier
Univ of Pittsburgh, Pittsburgh, PA, USA
OA8: ON DEMAND POST EXPOSURE PROPHYLAXIS WITH DOXYCYCLINE FOR MSM ENROLLED IN A PREP TRIAL
Jean-Michel Molina
St. Louis, Hosp, Paris, France
from CROI 2017 on February 15, 2017 12:15 PM-1:15 PM
DISCUSSION OF POSTER SESSION 4 – HIV AND SUBSTANCE USE: DOUBLE TROUBLE AND THEMED DISCUSSION SESSION 14 – HIV AND SUBSTANCE USE: DOUBLE TROUBLE
CHAIR
Susan P. Buchbinder
CROI Chair and University of California, San Francisco, CA, USA
TD14: "HOOKED ON PAINKILLERS" PRIOR TO FIRST INJECTION AMONG PWID IN 16 U.S. CITIES
Dita Broz
CDC, Atlanta, GA, USA
TD14: CHANGES IN PRESCRIPTION OPIOID, METH, AND COCAINE USE AMONG MSM IN 20 U.S. CITIES
Brooke Hoots
CDC, Atlanta, GA, USA
TD14: INCREASING METHAMPHETAMINE USE AMONG NON-MSM WHO INJECT DRUGS IN KING COUNTY, WA
Sara Glick
Univ of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 12:15 PM-1:15 PM
THEMED DISCUSSION LEADER
Ned Sacktor
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
CAN WE AFFORD TO WAIT? ART AND THE CNS
Kevin Robertson
University of North Carolina - Chapel Hill, Chapel Hill, NC, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
COGNITIVE TRAJECTORIES OVER 4 YEARS AMONG HIV+ WOMEN WITH OPTIMAL VIRAL SUPPRESSION
Leah H Rubin
University of Illinois at Chicago, Chicago, IL, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
CENICRIVIROC IMPROVES NEUROCOGNITION AND REDUCES MONOCYTE ACTIVATION IN TREATED HIV
Michelle L D'Antoni
University of Hawaii, Honolulu, HI, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
CSF INFLAMMATORY MARKERS AFTER ADDING MARAVIROC TO MONOTHERAPY DARUNAVIR/RITONAVIR
Tristan Barber
Chelsea and Westminster NHS Foundation Trust, London, United Kingdom
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
EXTENSIVE EFAVIRENZ METABOLISM IS ASSOCIATED WITH GREATER CNS TOXICITY
Robert Gross
University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
QUESTIONS AND ANSWERS
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION LEADER
Thor Wagner
University of Washington & Seattle Children's, Seattle, WA, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
CLONAL EXPANSION OF GENOME-INTACT HIV-1 IN FUNCTIONALLY POLARIZED T-CELL SUBSETS
Guinevere Q. Lee
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
INTACT PROVIRUSES ARE UNEQUALLY DISTRIBUTED IN T CELL SUBSETS DURING ART
Bonnie Hiener
The Westmead Institute for Medical Research, University of Sydney, Westmead, Australia
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
A SMALL FRACTION OF PROVIRUSES IN EXPANDED CLONES EXPRESS UNSPLICED HIV RNA IN VIVO
Andrew Musick
NIH/NCI, Frederick, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
PROLIFERATION OF CD4+ T CELLS CONTAINING REPLICATION-COMPETENT HIV-1
Zheng Wang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
CYTOTOXIC T LYMPHOCYTES MAY SHAPE THE HIV-1 PROVIRAL LANDSCAPE
Ya-Chi Ho
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 94